
Aducanumab is the first new drug approved to treat Alzheimer’s disease in nearly 20 years. But some in the medical community were stunned by the approval.
Aducanumab is the first new drug approved to treat Alzheimer’s disease in nearly 20 years. But some in the medical community were stunned by the approval.
This story was written by SweSwe Aye while participating in the USC Annenberg Center for Health Journalism's 2021 California Fellowship.
Dana Ullman is reporting on health-related stories for The Mendocino Voice with support from the USC Annenberg Center for Health Journalism. This article was produced as a series for the 2021 Center for Health Journalism California Fellowship.
African American are resilient, but enough is enough, says Observer senior staff writer.
How local leaders have taken vaccine distribution in underserved communities into their own hands.
About 2% of the country’s 15,000 licensed midwives are Black. In Southern California, there are about 120 licensed midwives, but only seven of them are Black.
Many of LA County’s programs focus on addressing the consequences of intergenerational racism on the health of Black women.
The most decorated U.S. track and field Olympian in history is using her star power to highlight the glaring disparities facing Black mothers.
In Long Beach, health officials say they’ve made progress in getting new people vaccinated in recent weeks, with a nearly 50% increase in daily doses administered.
The media has largely taken a pass on covering the dark side of Medicare Advantage plans, so people don't understand how the plans’ cost-sharing and provider networks really work.